XML 96 R76.htm IDEA: XBRL DOCUMENT v3.21.2
Business acquisition (Details) - iGenomX International Genomics Corporation (iGenomX)
$ in Thousands
Jun. 14, 2021
USD ($)
shares
Business Acquisition [Line Items]  
Fair value of consideration transferred $ 27,300
Cash consideration $ 490
Shares of the company's common stock | shares 237,409
Company common stock $ 26,772
Contingent consideration 5,500
Indemnity holdback consideration 4,924
Fair value of purchase consideration $ 37,653
Contingent consideration (in Shares) | shares 48,478
Indemnity holdback consideration (in Shares) | shares 43,662
Minimum  
Business Acquisition [Line Items]  
Contingent consideration payable period 6 months
Maximum  
Business Acquisition [Line Items]  
Contingent consideration payable period 12 months